Search

The proliferation of industrial-scale CO 2 capture technologies requires improvements in existing systems. Absorption/desorption capture processes that employ phase-change solvents (PCS) are promising for energy and cost reduction. Several PCSs have been investigated at bench scale, but very few have been tested in pilot-scale plants. The novel PCS mixture S 1 N (N1- cyclohexylpropane-1,3-diamine)/DMCA (Dimethylcyclohexylamine) has previously exhibited desirable performance in equilibrium experiments, economic and sustainability studies. This work presents the pilot-scale evaluation of S 1 N/DMCA for the first time, at two different concentrations and various liquid-to-gas ratios. Experimental evidence on key performance indicators is brought forward, including absorption efficiency, cyclic capacity, distance from equilibrium and regeneration energy in comparison to benchmark solvent MEA (monoethanolamine). S 1 N/DMCA enables robust operation as it maintains a cyclic capacity of 0.63 mol/kg at different liquid-to-gas ratios, which is about two times higher than that of MEA. It achieves operating loadings close to equilibrium, reaching 1.6 mol/kg, and a regeneration energy of 2.3 GJ/tn CO 2 , representing 45% reduction compared to MEA., (Copyright © 2022 Elsevier Ltd. All rights reserved.)

Background and Aim: Lung ultrasound (LUS) is a convenient imaging modality in the setting of coronavirus disease-19 (COVID-19) because it is easily available, can be performed bedside and repeated over time. We herein examined LUS patterns in relation to disease severity and disease stage among patients with COVID-19 pneumonia., Methods: We performed a retrospective case series analysis of patients with confirmed SARS-CoV-2 infection who were admitted to the hospital because of pneumonia. We recorded history, clinical parameters and medications. LUS was performed and scored in a standardized fashion by experienced operators, with evaluation of up to 12 lung fields, reporting especially on B-lines and consolidations., Results: We included 96 patients, 58.3% men, with a mean age of 65.9 years. Patients with a high-risk quick COVID-19 severity index (qCSI) were older and had worse outcomes, especially for the need for high-flow oxygen. B-lines and consolidations were located mainly in the lower posterior lung fields. LUS patterns for B-lines and consolidations were significantly worse in all lung fields among patients with high versus low qCSI. B-lines and consolidations were worse in the intermediate disease stage, from day 7 to 13 after onset of symptoms. While consolidations correlated more with inflammatory biomarkers, B-lines correlated more with end-organ damage, including extrapulmonary involvement., Conclusions: LUS patterns provide a comprehensive evaluation of patients with COVID-19 pneumonia that correlated with severity and dynamically reflect disease stage. LUS patterns may reflect different pathophysiological processes related to inflammation or tissue damage; consolidations may represent a more specific sign of localized disease, whereas B-lines seem to be also dependent upon generalized illness due to SARS-CoV-2 infection.